Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

An Incitative Multifaceted PROcedure for Pneumococcal Vaccination at the Emergency Department (IMPROVED)

22 januari 2020 uppdaterad av: Centre Hospitalier Princesse Grace

An Incitative Multifaceted PROcedure for Pneumococcal Vaccination at the Emergency Department; A Multicenter Prospective Randomized Open Trial The IMPROVED Project

Background :

Community-acquired pneumonia (CAP) is a threat in industrialized countries. It represents the 6th cause of death. CAP also frequently associates with other disorders responsible for admission and death. Among bacteria responsible for CAP, Streptococcus pneumonia is a major pathogen that is commonly involved and frequently leads to severe infection and admission. Categories at risk for this pathogen have been determined, and can be proposed anti-pneumococcal vaccination (APV) that efficiently and safely protects from this microorganism.

In the context of US health services, monocenter pilot experiences have reported improvement of pneumococcal prophylaxis implementing vaccination procedure at ED. A study that set in New Mexico (2003) reported a significant increase in APV (from 18% to 84%) when patients at risk were proposed vaccination at ED. To obtain these results, medical students were specifically trained and dedicated to screen and vaccinate against St. pneumoniae. Another single center trial (Tennessee, 2007) for APV at ED obtained an improvement (from 38.8 to 45.4%) when physicians were alerted for pneumococcal risk by the software they usually utilized at bedside. However these experiences remain sparse as additional dedicated resources are required or patients and attending ED physicians can be reluctant to proceed to vaccination at ED.

Mobile phone and derived communication modalities are current vectors to deliver information in several fields including education and medicine. Initially used in developing countries, short-message services (SMS) have improved behaviour of patients in various medical areas. In France, the investigators have observed that most patients above 50 years of age admitted after ED visit are equipped with mobile phone and can receive alerts by SMS.

These observations prompt us to propose a multifaceted procedure to improve APV after ED visit in at-risk patients, combining structured oral interview, written information and SMS as reminders.

Purpose : The investigators hypothesized that

  • a multifaceted intervention to promote anti-pneumococcal vaccination combining a structured oral interview, a written information to patient and his/her general practitioner, and a series of 3 SMS,
  • improves anti-pneumococcal vaccination at 6 months,
  • in at-risk patients (65+ years) visiting the emergency department. In order to answer this question, the investigators designed an interventional prospective multicenter randomized study (cluster).

Studieöversikt

Status

Avslutad

Betingelser

Studietyp

Observationell

Inskrivning (Faktisk)

1475

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

      • Clermont-ferrand, Frankrike, 63003
        • Centre Hospitalier Universitaire de Clermont-Ferrand
      • Issoire, Frankrike, 63503
        • Centre Hospitalier Paul Ardier
      • Marseille, Frankrike, 13015
        • AP-HM - Hôpital Nord
      • Marseille, Frankrike, 13385
        • AP-HM - La Timone
      • Marseille, Frankrike, 13915
        • Hia Laveran
      • Menton, Frankrike, 06507
        • Centre Hospitalier La Palmosa
      • Nice, Frankrike, 06003
        • Centre Hospitalier Universitaire De Nice
      • Orange, Frankrike, 84106
        • Centre Hospitalier Louis Giorgi
      • Paris, Frankrike, 75010
        • Hôpital Lariboisière
      • Paris, Frankrike, 75679
        • Hôpital Cochin
      • Paris, Frankrike, 75020
        • Hôpital Tenon
      • Paris, Frankrike, 75018
        • Hôpital Bichat-Claude Bernard
      • Paris, Frankrike, 75013
        • Hôpital Pitié-Salpêtrière
      • Saint-denis, Frankrike, 93200
        • Centre Hospitalier de Saint-Denis
      • Vaison-la-romaine, Frankrike, 84110
        • Centre Hospitalier de Vaison-la-Romaine
      • Valreas, Frankrike, 84600
        • Centre Hospitalier Jules Niel
      • Vichy, Frankrike, 03207
        • Centre Hospitalier Jacques Lacarin
      • Monaco, Monaco, 98000
        • Centre Hospitalier Princesse Grace

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

65 år och äldre (Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Testmetod

Sannolikhetsprov

Studera befolkning

patient aged 65 years or over who is not vaccinated against pneumoccocus virus during consultation with medical emergencies

Beskrivning

Inclusion Criteria:

  • patients 65-year old and above,
  • benefit from French or Monaco social security a social security.

Exclusion Criteria:

  • refuse to participate,
  • no possibility to receive SMS,
  • impaired cognitive functions and mental status precluding understanding of the study,
  • anticipated barriers precluding adequate follow-up (ex. homeless),
  • previous APV,
  • contraindication to APV,
  • do not understand/read French.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

Kohorter och interventioner

Grupp / Kohort
Multifaceted
  • brief structured interview with the physician about pneumococcal risk and vaccination,
  • information sheet delivered to patients with explanation about risk and benefit of APV,
  • letter given to patient for his/her general practitioner stating that the patient is at-risk for pneumococcal infection and could benefit of APV,
  • 3 SMS every 2 weeks to remind patients talking of pneumococcal risk with general practitioner.
Control
  • information sheet delivered to patients with explanation about the aim of the study,
  • brief interview with the physician about study.

Vad mäter studien?

Primära resultatmått

Resultatmått
Tidsram
Impact of a multifaceted procedure at ED visit on anti-pneumococcal vaccination. (APV) at 6-month. Evaluation criteria : Δ percentage (%) of APV vaccination at 6-month
Tidsram: 6 month
6 month

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
On Flu vaccination at 6-month Δ percentage (%)
Tidsram: 6 month
number of patients receiving vaccination against flu at 6-month. This issue will be collected by phone (patient, relative or general practioner). This will be a declarative data
6 month
On episodes of respiratory tract infections requiring antibiotics or admission at 6-month Δ (absolute number of events)
Tidsram: 6 month
number of patients who experienced respiratiory tract infection requiring antibiotics or admission. This issue will be collected by phone at 6-month (patient, relative or general practioner). This will be a declarative data
6 month
On death at 6- and 12-month (absolute number of events)
Tidsram: 6 month
6 month
On death related to infection at 6- and 12-month (absolute number of events)
Tidsram: 6 month
6 month
Psychosocial evaluation of patients and acceptance / refusal of vaccination
Tidsram: 6 month
The patient will fil a Psychosocial evaluation questionnaire during the ED visit. To achieve this issue, we will use the socio-economic indicators mobilized in investigations in social epidemiology: sex, age, education, occupation, housing, income and household size. This composite questionnaire will be used for qualitative analysis.
6 month

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Studierektor: Yann-Erick CLAESSENS, MD-PhD, Centre Hospitalier Princesse Grace
  • Studierektor: Xavier DUVAL, MD-PHD, Groupe Hospitalier Bichat Claude-Bernard
  • Studierektor: José LABARERE, MD, University Hospital, Grenoble
  • Studierektor: Jocelyn RAUDE, PHD, Ecole des Hautes Etudes en Santé Publique

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

1 november 2015

Primärt slutförande (Faktisk)

1 oktober 2016

Avslutad studie (Faktisk)

1 oktober 2017

Studieregistreringsdatum

Först inskickad

4 juli 2013

Först inskickad som uppfyllde QC-kriterierna

11 juli 2013

Första postat (Uppskatta)

15 juli 2013

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

23 januari 2020

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

22 januari 2020

Senast verifierad

1 oktober 2017

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera